Market Overview

SunTrust Highlights Upcoming Pharma Calendar, Favorite Names

SunTrust Highlights Upcoming Pharma Calendar, Favorite Names
Related IBB
Delta, Halliburton, Intel, IBB: 'Fast Money' Picks For January 9
Attention Biotech Investors: Brace For These January PDUFA Events
U.S. Biotech/Pharma Sector Daily Observations Letter: January 16, 2018 (Seeking Alpha)
Related LLY
Eli Lilly's Risks Could Be Underappreciated, Goldman Sachs Says In Downgrade
Alzheimer's Takes Another Hit As Pfizer Ends Research In The Area
Biotech Analysis Central Pharma News: Merck's Keytruda Rises, Celgene's Possible Next Move, Eiger's Phase 2 Dip (Seeking Alpha)

As the new week starts, SunTrust gave multiple reasons why they believe the pharmaceuticals group can outperform in 2016. SunTrust believes upward pressure on pharma names can be attributed to innovative new product cycles, accelerating long-term growth rates, an attractive 3 percent dividend yield and a favorable rising interest rate environment.

To take advantage of pricing concerns, SunTrust reviewed what may be key meetings and conferences this week in the pharmaceuticals sector.

  • European League Against Rheumatism: June 8-11
  • European Hematology Association: June 9-12
  • American Headache Society: June 9-12
  • American Diabetes Association: June 10-14
  • Associated Professional Sleep Societies: June 11-15

As for their favorite names in the space, based on growth and value, SunTrust said Bristol-Myers Squibb Co (NYSE: BMY), Eli Lilly and Co. (NYSE: LLY) and AbbVie Inc (NYSE: ABBV). However, Shire PLC (NASDAQ: SHPG) is actually their top name, and Supernus Pharmaceuticals Inc (NASDAQ: SUPN) rounds out their bullish picks as a specialty pharma "catch-up" trade.

The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) was trading down 0.91 percent at $265.17.

Posted-In: SunTrustAnalyst Color Biotech Previews Events Analyst Ratings Trading Ideas General


Related Articles (BMY + ABBV)

View Comments and Join the Discussion!